New transparency for drug company payments to doctors in the UK

Member companies of the Association of the British Pharmaceutical Industry (ABPI) have amended the ABPI Code of Practice for the Pharmaceutical Industry to require increased disclosure of payments within the healthcare community

ABPI logo
Rebecca Coombes the BMJ, sums up the new UK system for public disclosure of payments from drug companies to doctors, made available by the Association of the British Pharmaceutical Industry (ABPI).

Since the new year drug companies in the United Kingdom have begun recording any payments they make to doctors for certain services, such as chairing a meeting, in advance of plans to disclose the data to the public. This move echoes similar initiatives in the United States and the Netherlands designed to bring transparency to financial relationships between doctors, teaching hospitals, and drug companies. The information gathered over the next 12 months, and in subsequent years, will be uploaded to a publicly searchable database due to launch in July 2016… ”

Continue reading New year brings new transparency for drug company payments to doctors in UK, BMJ 2015;350:g7748.

Find more information about Disclosure of payments to individual healthcare professionals and Individual disclosure on the abpi website.

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

Have your say! Share your views

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.